Carlyle Group (CG) swings to Q1 2026 loss as carry turns negative
The Carlyle Group Inc. reported a net loss for the quarter ended March 31, 2026, driven by negative investment performance allocations. Total revenues fell to $254.0 million from $973.1 million a year earlier, as performance allocations swung to a loss of $681.1 million from income of $222.9 million.
Fund management fees were relatively stable at $584.0 million versus $586.1 million, while incentive fees rose to $51.7 million from $43.2 million. Net loss attributable to Carlyle was $132.2 million, compared with net income of $130.0 million, resulting in diluted earnings per share of $(0.37) versus $0.35.
Total assets increased to $29,842.0 million from $29,116.0 million as of December 31, 2025, with cash and cash equivalents of $1,673.2 million. Shares of common stock outstanding were 359,974,427 as of May 5, 2026.
Positive
- None.
Negative
- None.
Insights
Carlyle’s Q1 swung to a loss as carried interest turned negative despite steady fee revenue.
Carlyle Group showed how sensitive results are to investment performance. Total revenues dropped to $254.0 million from $973.1 million, mainly because performance allocations moved to a loss of $681.1 million versus prior-year income of $222.9 million. Core fund management fees held at $584.0 million, indicating a stable fee-earning asset base.
Expenses were helped by a reversal in performance-related compensation, with total compensation and benefits at a slight credit of $(21.0) million versus expense of $493.3 million a year earlier. However, consolidated funds generated a net investment loss of $64.4 million, adding to volatility.
Net loss attributable to Carlyle was $(132.2) million, or $(0.37) per diluted share, compared with earnings of $130.0 million and $0.35 per share. Total assets rose to $29,842.0 million, supported by higher investments of Consolidated Funds. Future filings will clarify whether negative performance allocations persist or normalize with market conditions.
Key Figures
Key Terms
Performance allocations financial
Fee-earning assets under management financial
Variable interest entities financial
Carried interest financial
Perpetual Capital financial
Consolidated Funds financial
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
4.625% Subordinated Notes due 2061 of Carlyle Finance L.L.C. |
☒ | Accelerated filer | ☐ | ||||
Non-accelerated filer | ☐ | Smaller reporting company | ||||
Emerging growth company | ||||||
Page | ||
PART I – FINANCIAL INFORMATION | ||
Item 1. | Financial Statements | 5 |
Unaudited Condensed Consolidated Financial Statements – March 31, 2026 and 2025: | ||
Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025 | 5 | |
Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2026 and 2025 | 6 | |
Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three Months Ended March 31, 2026 and 2025 | 7 | |
Condensed Consolidated Statements of Changes in Equity for the Three Months Ended March 31, 2026 and 2025 | 8 | |
Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2026 and 2025 | 9 | |
Notes to the Condensed Consolidated Financial Statements | 11 | |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 60 |
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 111 |
Item 4. | Controls and Procedures | 111 |
PART II – OTHER INFORMATION | ||
Item 1. | Legal Proceedings | 113 |
Item 1A. | Risk Factors | 113 |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 113 |
Item 3. | Defaults Upon Senior Securities | 113 |
Item 4. | Mine Safety Disclosures | 113 |
Item 5. | Other Information | 113 |
Item 6. | Exhibits | 114 |
SIGNATURES | 115 | |
March 31, 2026 | December 31, 2025 | ||
(Unaudited) | |||
Assets | |||
Cash and cash equivalents | $ | $ | |
Cash and cash equivalents held at Consolidated Funds | |||
Investments, including accrued performance allocations of $ March 31, 2026 and December 31, 2025, respectively | |||
Investments of Consolidated Funds | |||
Due from affiliates and other receivables, net | |||
Due from affiliates and other receivables of Consolidated Funds, net | |||
Fixed assets, net | |||
Lease right-of-use assets, net | |||
Deposits and other | |||
Intangible assets, net | |||
Deferred tax assets | |||
Total assets | $ | $ | |
Liabilities and equity | |||
Debt obligations | $ | $ | |
Loans payable of Consolidated Funds | |||
Accounts payable, accrued expenses and other liabilities | |||
Accrued compensation and benefits | |||
Due to affiliates | |||
Deferred revenue | |||
Deferred tax liabilities | |||
Other liabilities of Consolidated Funds | |||
Lease liabilities | |||
Accrued giveback obligations | |||
Total liabilities | |||
Commitments and contingencies | |||
Common stock, $ respectively) | |||
Additional paid-in-capital | |||
Retained earnings | |||
Accumulated other comprehensive loss | ( | ( | |
Non-controlling interests in consolidated entities | |||
Total equity | |||
Total liabilities and equity | $ | $ |
Three Months Ended March 31, | |||
2026 | 2025 | ||
Revenues | |||
Fund management fees | $ | $ | |
Incentive fees | |||
Investment income (loss) | |||
Performance allocations | ( | ||
Principal investment income (loss) | ( | ||
Total investment income (loss) | ( | ||
Interest and other income | |||
Interest and other income of Consolidated Funds | |||
Total revenues | |||
Expenses | |||
Compensation and benefits | |||
Cash-based compensation and benefits | |||
Equity-based compensation | |||
Performance allocations and incentive fee related compensation | ( | ||
Total compensation and benefits | ( | ||
General, administrative and other expenses | |||
Interest | |||
Interest and other expenses of Consolidated Funds | |||
Total expenses | |||
Other income (loss) | |||
Net investment income (loss) of Consolidated Funds | ( | ||
Income (loss) before provision for income taxes | ( | ||
Provision (benefit) for income taxes | ( | ||
Net income (loss) | ( | ||
Net income (loss) attributable to non-controlling interests in consolidated entities | ( | ||
Net income (loss) attributable to The Carlyle Group Inc. | $( | $ | |
Net income (loss) attributable to The Carlyle Group Inc. per common share (see Note 11) | |||
Basic | $( | $ | |
Diluted | $( | $ | |
Weighted-average common shares | |||
Basic | |||
Diluted | |||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Net income (loss) | $( | $ | |
Other comprehensive income (loss) | |||
Foreign currency translation adjustments | ( | ||
Defined benefit plans | |||
Unrealized loss for the period | ( | ( | |
Reclassification adjustment for loss during the period, included in cash-based compensation and benefits expense | ( | ( | |
Other comprehensive income (loss) | ( | ||
Comprehensive income (loss) | ( | ||
Comprehensive income (loss) attributable to non-controlling interests in consolidated entities | ( | ||
Comprehensive income (loss) attributable to The Carlyle Group Inc. | $( | $ | |
Common Shares | Common Stock | Additional Paid-in- Capital | Retained Earnings | Accumulated Other Comprehensive Loss | Non- controlling Interests in Consolidated Entities | Total Equity | |||||||
Balance at December 31, 2025 | $ | $ | $ | $( | $ | $ | |||||||
Shares repurchased | ( | — | — | ( | — | — | ( | ||||||
Net shares issued for equity-based awards | — | — | ( | — | — | ( | |||||||
Equity-based compensation | — | — | — | — | — | ||||||||
Dividend-equivalent rights on certain equity- based awards | — | — | ( | — | — | ||||||||
Contributions | — | — | — | — | — | ||||||||
Dividends and distributions | — | — | — | ( | — | ( | ( | ||||||
Net loss | — | — | — | ( | — | ( | ( | ||||||
Currency translation adjustments | — | — | — | — | ( | ( | ( | ||||||
Defined benefit plans, net | — | — | — | — | ( | — | ( | ||||||
Balance at March 31, 2026 | $ | $ | $ | $( | $ | $ |
Common Shares | Common Stock | Additional Paid-in- Capital | Retained Earnings | Accumulated Other Comprehensive Loss | Non- controlling Interests in Consolidated Entities | Total Equity | |||||||
Balance at December 31, 2024 | $ | $ | $ | $( | $ | $ | |||||||
Shares repurchased | ( | — | — | ( | — | — | ( | ||||||
Net shares issued for equity-based awards | — | — | ( | — | — | ( | |||||||
Equity-based compensation | — | — | — | — | — | ||||||||
Dividend-equivalent rights on certain equity- based awards | — | — | ( | — | — | ||||||||
Initial consolidation of a Consolidated Entity | — | — | — | — | — | ||||||||
Contributions | — | — | — | — | — | ||||||||
Dividends and distributions | — | — | — | ( | — | ( | ( | ||||||
Net income | — | — | — | — | |||||||||
Currency translation adjustments | — | — | — | — | |||||||||
Defined benefit plans, net | — | — | — | — | ( | — | ( | ||||||
Balance at March 31, 2025 | $ | $ | $ | $( | $ | $ |
Three Months Ended March 31, | |||
2026 | 2025 | ||
Cash flows from operating activities | |||
Net income (loss) | $( | $ | |
Adjustments to reconcile net income to net cash flows from operating activities: | |||
Depreciation and amortization | |||
Equity-based compensation | |||
Non-cash performance allocations and incentive fees, net | |||
Non-cash principal investment (income) loss | ( | ||
Other non-cash amounts | ( | ||
Consolidated Funds related: | |||
Realized/unrealized (gain) loss on investments of Consolidated Funds | ( | ||
Realized/unrealized (gain) loss from loans payable of Consolidated Funds | ( | ||
Purchases of investments by Consolidated Funds | ( | ( | |
Proceeds from sales and settlements of investments by Consolidated Funds | |||
Non-cash interest income, net | ( | ( | |
Change in cash and cash equivalents held at Consolidated Funds | |||
Change in other receivables held at Consolidated Funds | ( | ||
Change in other liabilities held at Consolidated Funds | ( | ||
Purchases of investments | ( | ( | |
Proceeds from the sale of investments | |||
Payments of contingent consideration | ( | ||
Changes in deferred taxes, net | ( | ( | |
Change in due from affiliates and other receivables | ( | ||
Change in deposits and other | ( | ||
Change in accounts payable, accrued expenses and other liabilities | ( | ( | |
Change in accrued compensation and benefits | ( | ( | |
Change in due to affiliates | |||
Change in lease right-of-use assets and lease liabilities | ( | ( | |
Change in deferred revenue | |||
Net cash used in operating activities | ( | ( | |
Cash flows from investing activities | |||
Purchases of fixed assets, net | ( | ( | |
Net cash used in investing activities | ( | ( | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
Cash flows from financing activities | |||
Payments on CLO borrowings | ( | ( | |
Proceeds from CLO borrowings, net of financing costs | |||
Net borrowings on loans payable of Consolidated Funds | |||
Dividends to common stockholders | ( | ( | |
Contributions from non-controlling interest holders | |||
Distributions to non-controlling interest holders | ( | ( | |
Common shares repurchased and net share settlement of equity-based awards | ( | ( | |
Change in due to/from affiliates financing activities | |||
Net cash provided by financing activities | |||
Effect of foreign exchange rate changes | ( | ||
Decrease in cash, cash equivalents and restricted cash | ( | ( | |
Cash, cash equivalents and restricted cash, beginning of period | |||
Cash, cash equivalents and restricted cash, end of period | $ | $ | |
Supplemental non-cash disclosures | |||
Initial consolidation of Consolidated Funds | $( | $ | |
Reconciliation of cash, cash equivalents and restricted cash, end of period: | |||
Cash and cash equivalents | $ | $ | |
Restricted cash | |||
Total cash, cash equivalents and restricted cash, end of period | $ | $ | |
Cash and cash equivalents held at Consolidated Funds | $ | $ | |
As of | |||
March 31, 2026 | December 31, 2025 | ||
(Dollars in millions) | |||
Investments | $ | $ | |
Accrued performance allocations | |||
Management fee receivables | |||
Total | $ | $ | |
As of | |||
March 31, 2026 | December 31, 2025 | ||
(Dollars in millions) | |||
Currency translation adjustments | $( | $( | |
Unrealized losses on defined benefit plans | |||
Total | $( | $( | |
(Dollars in millions) | Level I | Level II | Level III | Total | |||
Assets | |||||||
Investments of Consolidated Funds(1): | |||||||
Equity securities(2) | $ | $ | $ | $ | |||
Bonds | |||||||
Loans | |||||||
Investments in CLOs and other: | |||||||
Investments in CLOs | |||||||
Other investments(3) | |||||||
Foreign currency forward contracts | |||||||
Subtotal | $ | $ | $ | $ | |||
Investments measured at net asset value | |||||||
Total | $ | ||||||
Liabilities | |||||||
Loans payable of Consolidated Funds(4)(5) | $ | $ | $ | $ | |||
Foreign currency forward contracts | |||||||
Total | $ | $ | $ | $ |
(Dollars in millions) | Level I | Level II | Level III | Total | |||
Assets | |||||||
Investments of Consolidated Funds(1): | |||||||
Equity securities(2) | $ | $ | $ | $ | |||
Bonds | |||||||
Loans | |||||||
Investments in CLOs and other: | |||||||
Investments in CLOs | |||||||
Other investments(3) | |||||||
Foreign currency forward contracts | |||||||
Subtotal | $ | $ | $ | $ | |||
Investments measured at net asset value | |||||||
Total | $ | ||||||
Liabilities | |||||||
Loans payable of Consolidated Funds(4)(5) | $ | $ | $ | $ | |||
Foreign currency forward contracts | |||||||
Total | $ | $ | $ | $ |
Financial Assets | |||||||||||
Three Months Ended March 31, 2026 | |||||||||||
Investments of Consolidated Funds | |||||||||||
Equity securities | Bonds | Loans | Investments in CLOs | Other investments | Total | ||||||
Balance, beginning of period | $ | $ | $ | $ | $ | $ | |||||
Initial consolidation of funds(1) | |||||||||||
Purchases | |||||||||||
Sales and distributions | ( | ( | ( | ( | ( | ( | |||||
Settlements | ( | ( | |||||||||
Realized and unrealized gains (losses), net | |||||||||||
Included in earnings | ( | ( | ( | ( | ( | ( | |||||
Included in other comprehensive income | ( | ( | ( | ( | |||||||
Balance, end of period | $ | $ | $ | $ | $ | $ | |||||
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date | $( | $( | $( | $( | $( | $( | |||||
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date | $ | $( | $( | $( | $ | $( | |||||
Financial Assets | |||||||||||
Three Months Ended March 31, 2025 | |||||||||||
Investments of Consolidated Funds | |||||||||||
Equity securities | Bonds | Loans | Investments in CLOs | Other investments | Total | ||||||
Balance, beginning of period | $ | $ | $ | $ | $ | $ | |||||
Initial consolidation of funds(1) | |||||||||||
Transfers out(2) | ( | ( | |||||||||
Purchases | |||||||||||
Sales and distributions | ( | ( | ( | ( | ( | ( | |||||
Settlements | ( | ( | |||||||||
Realized and unrealized gains (losses), net | |||||||||||
Included in earnings | ( | ||||||||||
Included in other comprehensive income | |||||||||||
Balance, end of period | $ | $ | $ | $ | $ | $ | |||||
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date | $ | $ | $ | $ | $ | $ | |||||
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date | $ | $ | $ | $ | $ | $ | |||||
Financial Liabilities | |||
Loans Payable of Consolidated Funds | |||
Three Months Ended March 31, | |||
2026 | 2025 | ||
Balance, beginning of period | $ | $ | |
Initial consolidation of funds(1) | |||
Borrowings | |||
Paydowns | ( | ( | |
Sales | ( | ( | |
Realized and unrealized (gains) losses, net | |||
Included in earnings | ( | ||
Included in other comprehensive income | ( | ||
Balance, end of period | $ | $ | |
Changes in unrealized (gains) losses included in earnings related to financial liabilities still held at the reporting date | $( | $ | |
Changes in unrealized (gains) losses included in other comprehensive income related to financial liabilities still held at the reporting date | $( | $ | |
Fair Value at | Valuation Technique(s) | Unobservable Input(s) | Range (Weighted Average) | Impact to Valuation from Increase in Input | |||||
(Dollars in millions) | March 31, 2026 | ||||||||
Assets | |||||||||
Investments of Consolidated Funds: | |||||||||
Equity securities | $ | Consensus Pricing | Indicative Quotes ($ per share) | Higher | |||||
Discounted Cash Flow | Discount Rates | Lower | |||||||
Terminal Growth Rate | Higher | ||||||||
Comparable Multiple | EBITDA Multiple | Higher | |||||||
Revenue Multiple | Higher | ||||||||
Discounted Cash Flow | Discount Rates | Lower | |||||||
Constant Prepayment Rate | Lower | ||||||||
Constant Default Rate | Lower | ||||||||
Recovery Rate | Higher | ||||||||
Other(1) | N/A | N/A | N/A | ||||||
Bonds | Consensus Pricing | Indicative Quotes (% of Par) | Higher | ||||||
Loans | Consensus Pricing | Indicative Quotes (% of Par) | Higher | ||||||
Discounted Cash Flow | Discount Rates | Lower | |||||||
Constant Prepayment Rate | Lower | ||||||||
Constant Default Rate | Lower | ||||||||
Severity | Higher | ||||||||
Other(1) | N/A | N/A | N/A | ||||||
Investments in CLOs: | |||||||||
Senior secured notes | Consensus Pricing with Discounted Cash Flow | Indicative Quotes (% of Par) | Higher | ||||||
Discount Margins (Basis Points) | Lower | ||||||||
Default Rates | Lower | ||||||||
Recovery Rates | Higher | ||||||||
Subordinated notes and preferred shares | Consensus Pricing with Discounted Cash Flow | Indicative Quotes (% of Par) | Higher | ||||||
Discount Rates | Lower | ||||||||
Default Rates | Lower | ||||||||
Recovery Rates | Higher | ||||||||
Other investments: | |||||||||
Aviation subordinated notes | Discounted Cash Flow | Discount Rates | Lower | ||||||
Loans | Consensus Pricing with Discounted Cash Flow | Indicative Quotes (% of Par) | Higher | ||||||
Discount Rates | Lower | ||||||||
Other(1) | N/A | N/A | N/A | ||||||
Total | $ | ||||||||
Liabilities | |||||||||
Loans payable of Consolidated Funds: | |||||||||
Senior secured notes | $ | Other(2) | N/A | N/A | N/A | ||||
Subordinated notes and preferred shares | Consensus Pricing with Discounted Cash Flow | Indicative Quotes (% of Par) | Higher | ||||||
Discount Rates | Lower | ||||||||
Default Rates | Lower | ||||||||
Recovery Rates | Higher | ||||||||
Total | $ |
Fair Value at | Valuation Technique(s) | Unobservable Input(s) | Range (Weighted Average) | Impact to Valuation from Increase in Input | |||||
(Dollars in millions) | December 31, 2025 | ||||||||
Assets | |||||||||
Investments of Consolidated Funds: | |||||||||
Equity securities | $ | Consensus Pricing | Indicative Quotes ($ per share) | Higher | |||||
Discounted Cash Flow | Discount Rates | Lower | |||||||
Terminal Growth Rate | Higher | ||||||||
Comparable Multiple | EBITDA Multiple | Higher | |||||||
Revenue Multiple | Higher | ||||||||
TCF Multiple | Higher | ||||||||
Discounted Cash Flow | Discount Rates | Lower | |||||||
Constant Prepayment Rate | Lower | ||||||||
Constant Default Rate | Lower | ||||||||
Recovery Rate | Higher | ||||||||
Other(1) | N/A | N/A | N/A | ||||||
Bonds | Consensus Pricing | Indicative Quotes (% of Par) | Higher | ||||||
Loans | Consensus Pricing | Indicative Quotes (% of Par) | Higher | ||||||
Discounted Cash Flow | Discount Rates | Lower | |||||||
Discounted Cash Flow | Discount Rates | Lower | |||||||
Constant Prepayment Rate | Lower | ||||||||
Constant Default Rate | Lower | ||||||||
Other | Other(1) | N/A | N/A | N/A | |||||
Investments in CLOs | |||||||||
Senior secured notes | Discounted Cash Flow with Consensus Pricing | Indicative Quotes (% of Par) | Higher | ||||||
Discount Margins (Basis Points) | Lower | ||||||||
Default Rates | Lower | ||||||||
Recovery Rates | Higher | ||||||||
Subordinated notes and preferred shares | Discounted Cash Flow with Consensus Pricing | Indicative Quotes (% of Par) | Higher | ||||||
Discount Rate | Lower | ||||||||
Default Rates | Lower | ||||||||
Recovery Rates | Higher | ||||||||
Other investments: | |||||||||
Aviation subordinated notes | Discounted Cash Flow | Discount Rates | Lower | ||||||
Loans | Discounted Cash Flow | Discount Rates | Lower | ||||||
Consensus Pricing | Indicative Quotes (% of Par) | Higher | |||||||
Other(1) | N/A | N/A | N/A | ||||||
Total | $ | ||||||||
Liabilities | |||||||||
Loans payable of Consolidated Funds: | |||||||||
Senior secured notes | $ | Other(2) | N/A | N/A | N/A | ||||
Subordinated notes and preferred shares | Discounted Cash Flow with Consensus Pricing | Indicative Quotes (% of Par) | Higher | ||||||
Discount Rates | Lower | ||||||||
Default Rates | Lower | ||||||||
Recovery Rates | Higher | ||||||||
Total | $ |
As of | |||
March 31, 2026 | December 31, 2025 | ||
(Dollars in millions) | |||
Accrued performance allocations | $ | $ | |
Principal equity method investments, excluding performance allocations | |||
Principal investments in CLOs | |||
Other investments | |||
Total | $ | $ | |
As of | |||
March 31, 2026 | December 31, 2025 | ||
(Dollars in millions) | |||
Global Private Equity | $ | $ | |
Global Credit | |||
Carlyle AlpInvest | |||
Total | $ | $ | |
As of | |||
March 31, 2026 | December 31, 2025 | ||
(Dollars in millions) | |||
Global Private Equity | $( | $( | |
Global Credit | ( | ( | |
Total | $( | $( | |
As of | |||
March 31, 2026 | December 31, 2025 | ||
(Dollars in millions) | |||
Global Private Equity(1) | $ | $ | |
Global Credit(2) | |||
Carlyle AlpInvest | |||
Total | $ | $ | |
As of | |||
March 31, 2026 | December 31, 2025 | ||
(Dollars in millions) | |||
Investment in NGP Management | $ | $ | |
Investments in NGP general partners - accrued performance allocations | |||
Principal investments in NGP funds | |||
Total investments in NGP | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Management fee related revenues from NGP Management | $ | $ | |
Expenses related to the investment in NGP Management | ( | ( | |
Amortization of basis differences and impairment of investment in NGP Management | ( | ( | |
Net investment income (loss) from NGP Management | $ | $( | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Performance allocations | |||
Realized | $ | $ | |
Unrealized | ( | ( | |
( | |||
Principal investment income (loss) from equity method investments (excluding performance allocations) | |||
Realized | ( | ||
Unrealized | ( | ||
( | |||
Principal investment income (loss) from investments in CLOs and other investments | |||
Realized | ( | ||
Unrealized | ( | ||
( | ( | ||
Total | $( | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Global Private Equity | $( | $ | |
Global Credit | |||
Carlyle AlpInvest | ( | ||
Total | $( | $ | |
Three Months Ended March 31, 2026 | ||
(Dollars in millions) | ||
Global Private Equity | Carlyle Partners VII, L.P. | $( |
Three Months Ended March 31, 2025 | ||
(Dollars in millions) | ||
Global Private Equity | Carlyle Partners VII, L.P. | $ |
Global Private Equity | Carlyle Asia Partners V, L.P. | ( |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Global Private Equity | $ | $( | |
Global Credit | |||
Carlyle AlpInvest | |||
Total | $ | $( | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Interest income from investments | $ | $ | |
Other income | |||
Total | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Gains (losses) from investments of Consolidated Funds | $( | $ | |
Gains (losses) from liabilities of consolidated CLOs | ( | ||
Total | $( | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Net realized gains (losses) | $ | $( | |
Net change in unrealized gains (losses) | ( | ||
Total | $( | $ | |
March 31, 2026 | December 31, 2025 | ||||||
Borrowing Outstanding | Carrying Value | Borrowing Outstanding | Carrying Value | ||||
(Dollars in millions) | |||||||
CLO Borrowings (See below) | $ | $ | $ | $ | |||
Total debt obligations | $ | $ | $ | $ | |||
As of March 31, 2026 | As of December 31, 2025 | ||||||||||
Borrowing Outstanding | Weighted Average Interest Rate | Weighted Average Remaining Maturity in Years | Borrowing Outstanding | Weighted Average Interest Rate | Weighted Average Remaining Maturity in Years | ||||||
Total CLO borrowings | $ | $ | |||||||||
Interest Expense | |||||||||
Fair Value (1) As of | Three Months Ended March 31, | ||||||||
Aggregate Principal Amount | March 31, 2026 | December 31, 2025 | 2026 | 2025 | |||||
$ | $ | $ | $ | $ | |||||
$ | $ | ||||||||
As of March 31, 2026 | |||||||||
Borrowing Outstanding | Fair Value | Weighted Average Interest Rate | Weighted Average Remaining Maturity in Years | ||||||
Senior secured notes(1) | $ | $ | |||||||
Subordinated notes | N/A | (3) | |||||||
Revolving credit facilities(2) | |||||||||
Total | $ | $ | |||||||
As of December 31, 2025 | |||||||||
Borrowing Outstanding | Fair Value | Weighted Average Interest Rate | Weighted Average Remaining Maturity in Years | ||||||
Senior secured notes(1) | $ | $ | |||||||
Subordinated notes | N/A | (3) | |||||||
Revolving credit facilities(2) | |||||||||
Total | $ | $ | |||||||
As of | |||
March 31, 2026 | December 31, 2025 | ||
(Dollars in millions) | |||
Accrued performance allocations and incentive fee related compensation | $ | $ | |
Accrued bonuses | |||
Realized performance allocations and incentive fee related compensation not yet paid | |||
Other | |||
Total | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Realized | $ | $ | |
Unrealized | ( | ( | |
Total | $( | $ | |
As of | |||
March 31, 2026 | December 31, 2025 | ||
(Dollars in millions) | |||
Accrued incentive fees | $ | $ | |
Unbilled receivable for giveback obligations from current and former employees | |||
Notes receivable and accrued interest from affiliates | |||
Management fee receivable, net | |||
Reimbursable expenses and other receivables from unconsolidated funds and affiliates, net | |||
Total | $ | $ | |
As of | |||
March 31, 2026 | December 31, 2025 | ||
(Dollars in millions) | |||
Due to affiliates of Consolidated Funds | $ | $ | |
Due to non-consolidated affiliates | |||
Amounts owed under the tax receivable agreement | |||
Other | |||
Total | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Provision (benefit) for income taxes | $( | $ | |
Effective tax rate | |||
As of | |||
March 31, 2026 | December 31, 2025 | ||
(Dollars in millions) | |||
Non-Carlyle interests in Consolidated Funds | $ | $ | |
Non-Carlyle interests in majority-owned subsidiaries | |||
Non-controlling interests in carried interest and giveback obligations | ( | ||
Non-controlling interests in consolidated entities | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Non-Carlyle interests in Consolidated Funds | $( | $ | |
Non-Carlyle interests in majority-owned subsidiaries | ( | ||
Non-controlling interests in carried interest and giveback obligations | ( | ||
Non-controlling interests in income (loss) of consolidated entities | $( | $ | |
Three Months Ended March 31, 2026 | |||
Basic | Diluted | ||
Net loss attributable to common shares | $( | $( | |
Weighted-average common shares outstanding | |||
Net loss per common share | $( | $( | |
Three Months Ended March 31, 2025 | |||
Basic | Diluted | ||
Net income attributable to common shares | $ | $ | |
Weighted-average common shares outstanding | |||
Net income per common share | $ | $ | |
Three Months Ended March 31, 2026 | |||
Basic | Diluted | ||
The Carlyle Group Inc. weighted-average common shares outstanding | |||
Unvested restricted stock units | |||
Issuable common shares and performance-vesting restricted stock units | |||
Weighted-average common shares outstanding | |||
Three Months Ended March 31, 2025 | |||
Basic | Diluted | ||
The Carlyle Group Inc. weighted-average common shares outstanding | |||
Unvested restricted stock units | |||
Issuable common shares and performance-vesting restricted stock units | |||
Weighted-average common shares outstanding | |||
Three Months Ended March 31, | |||||
2026 | 2025 | ||||
Shares | $ | Shares | $ | ||
(Dollars in millions, except share data) | |||||
Shares repurchased | $ | $ | |||
Shares retired in connection with the net share settlement of equity-based awards | |||||
Total | $ | $ | |||
Dividend Record Date | Dividend Payment Date | Dividend per Common Share | Dividend to Common Stockholders | |||
(Dollars in millions, except per share data) | ||||||
May 19, 2025 | May 27, 2025 | $ | $ | |||
August 18, 2025 | August 28, 2025 | |||||
November 10, 2025 | November 19, 2025 | |||||
February 16, 2026 | February 20, 2026 | |||||
Total 2025 Dividend Year | $ | $ | ||||
May 18, 2026 | May 28, 2026 | $ | $ | |||
Total 2026 Dividend Year (through Q1 2026) | $ | $ | ||||
Unvested Shares | Performance- Vesting Restricted Stock Units | Weighted- Average Grant Date Fair Value | Restricted Stock Units | Weighted- Average Grant Date Fair Value | Unvested Common Shares | Weighted- Average Grant Date Fair Value | |||||
Balance, December 31, 2025 | $ | $ | $ | ||||||||
Granted (1) | $ | $ | $ | ||||||||
Vested (2) | $ | $ | $ | ||||||||
Forfeited | $ | $ | $ | ||||||||
Balance, March 31, 2026 | $ | $ | $ |
Global Private Equity | Global Credit | Carlyle AlpInvest | Total | ||||
(Dollars in millions) | |||||||
Segment Revenues | |||||||
Fund level fee revenues | |||||||
Fund management fees | $ | $ | $ | $ | |||
Portfolio advisory and transaction fees, net and other | |||||||
Fee related performance revenues | |||||||
Total fund level fee revenues | |||||||
Realized performance revenues | |||||||
Realized principal investment income | |||||||
Interest income | |||||||
Total revenues | |||||||
Segment Expenses | |||||||
Compensation and benefits | |||||||
Cash-based compensation and benefits | |||||||
Realized performance revenues related compensation | |||||||
Total compensation and benefits | |||||||
General, administrative, and other indirect expenses(1) | |||||||
Depreciation and amortization expense | |||||||
Interest expense | |||||||
Total expenses | |||||||
(=) Distributable Earnings | $ | $ | $ | $ | |||
(-) Realized net performance revenues | |||||||
(-) Realized principal investment income | |||||||
(+) Net interest | |||||||
(=) Fee Related Earnings | $ | $ | $ | $ | |||
Three Months Ended March 31, 2025 | |||||||
Global Private Equity | Global Credit | Carlyle AlpInvest | Total | ||||
(Dollars in millions) | |||||||
Segment Revenues | |||||||
Fund level fee revenues | |||||||
Fund management fees | $ | $ | $ | $ | |||
Portfolio advisory and transaction fees, net and other | |||||||
Fee related performance revenues | |||||||
Total fund level fee revenues | |||||||
Realized performance revenues | |||||||
Realized principal investment income | |||||||
Interest income | |||||||
Total revenues | |||||||
Segment Expenses | |||||||
Compensation and benefits | |||||||
Cash-based compensation and benefits | |||||||
Realized performance revenues related compensation | |||||||
Total compensation and benefits | |||||||
General, administrative, and other indirect expenses(1) | |||||||
Depreciation and amortization expense | |||||||
Interest expense | |||||||
Total expenses | |||||||
(=) Distributable Earnings | $ | $ | $ | $ | |||
(-) Realized net performance revenues | |||||||
(-) Realized principal investment income | |||||||
(+) Net interest | |||||||
(=) Fee Related Earnings | $ | $ | $ | $ | |||
Three Months Ended March 31, 2026 | |||||||||
Total Reportable Segments | Consolidated Funds | Reconciling Items | Carlyle Consolidated | ||||||
(Dollars in millions) | |||||||||
Revenues | $ | $ | $( | (a) | $ | ||||
Expenses | $ | $ | $( | (b) | $ | ||||
Other income (loss) | $ | $( | $ | (c) | $( | ||||
Distributable Earnings | $ | $( | $( | (d) | $( | ||||
Three Months Ended March 31, 2025 | |||||||||
Total Reportable Segments | Consolidated Funds | Reconciling Items | Carlyle Consolidated | ||||||
(Dollars in millions) | |||||||||
Revenues | $ | $ | $( | (a) | $ | ||||
Expenses | $ | $ | $ | (b) | $ | ||||
Other income (loss) | $ | $ | $ | (c) | $ | ||||
Distributable Earnings | $ | $ | $( | (d) | $ | ||||
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Unrealized performance and fee related performance revenues | $( | $( | |
Unrealized principal investment income (loss) | ( | ||
Adjustments related to expenses associated with investments in NGP Management and its affiliates | ( | ( | |
Non-controlling interests and other adjustments to present certain costs on a net basis | |||
Elimination of revenues of Consolidated Funds | ( | ||
$( | $( | ||
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Total Reportable Segments - Fund level fee revenues | $ | $ | |
Adjustments(1) | ( | ( | |
Carlyle Consolidated - Fund management fees | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Total Reportable Segments - Portfolio advisory and transaction fees, net and other | $ | $ | |
Adjustments(1) | ( | ( | |
Carlyle Consolidated - Portfolio advisory and transaction fees, net | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Unrealized performance and fee related performance revenue compensation expense | $( | $( | |
Equity-based compensation | |||
Acquisition or disposition-related charges and amortization of intangibles and impairment | |||
Tax (expense) benefit associated with certain foreign performance revenues related compensation | |||
Non-controlling interests and other adjustments to present certain costs on a net basis | ( | ||
Other adjustments | |||
Elimination of expenses of Consolidated Funds | ( | ( | |
$( | $ | ||
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Income (loss) before provision for income taxes | $( | $ | |
Adjustments: | |||
Net unrealized performance and fee related performance revenues | |||
Unrealized principal investment (income) loss | ( | ||
Equity-based compensation(1) | |||
Acquisition or disposition-related charges, including amortization of intangibles and impairment | |||
Tax (expense) benefit associated with certain foreign performance revenues | |||
Net (income) loss attributable to non-controlling interests in consolidated entities | ( | ||
Other adjustments(2) | |||
Distributable Earnings | $ | $ | |
(-) Realized performance revenues, net of related compensation(3) | |||
(-) Realized principal investment income(3) | |||
(+) Net interest | |||
Fee Related Earnings | $ | $ | |
Three Months Ended March 31, 2026 | |||||
Carlyle Consolidated | Adjustments (4) | Total Reportable Segments | |||
(Dollars in millions) | |||||
Performance revenues | $( | $ | $ | ||
Performance revenues related compensation expense | ( | ||||
Net performance revenues | $( | $ | $ | ||
Principal investment income (loss) | $ | $( | $ | ||
Three Months Ended March 31, 2025 | |||||
Carlyle Consolidated | Adjustments (4) | Total Reportable Segments | |||
(Dollars in millions) | |||||
Performance revenues | $ | $ | $ | ||
Performance revenues related compensation expense | |||||
Net performance revenues | $ | $ | $ | ||
Principal investment income (loss) | $( | $ | $ | ||
As of March 31, 2026 | |||||||
Consolidated Operating Entities | Consolidated Funds | Eliminations | Consolidated | ||||
(Dollars in millions) | |||||||
Assets | |||||||
Cash and cash equivalents | $ | $ | $ | $ | |||
Cash and cash equivalents held at Consolidated Funds | |||||||
Investments, including accrued performance allocations of $ | ( | ||||||
Investments of Consolidated Funds | |||||||
Due from affiliates and other receivables, net | ( | ||||||
Due from affiliates and other receivables of Consolidated Funds, net | |||||||
Fixed assets, net | |||||||
Lease right-of-use assets, net | |||||||
Deposits and other | |||||||
Intangible assets, net | |||||||
Deferred tax assets | |||||||
Total assets | $ | $ | $( | $ | |||
Liabilities and equity | |||||||
Debt obligations | $ | $ | $ | $ | |||
Loans payable of Consolidated Funds | ( | ||||||
Accounts payable, accrued expenses and other liabilities | |||||||
Accrued compensation and benefits | |||||||
Due to affiliates | |||||||
Deferred revenue | |||||||
Deferred tax liabilities | |||||||
Other liabilities of Consolidated Funds | ( | ||||||
Lease liabilities | |||||||
Accrued giveback obligations | |||||||
Total liabilities | ( | ||||||
Common stock | |||||||
Additional paid-in capital | ( | ||||||
Retained earnings | |||||||
Accumulated other comprehensive loss | ( | ( | |||||
Non-controlling interests in consolidated entities | |||||||
Total equity | ( | ||||||
Total liabilities and equity | $ | $ | $( | $ | |||
As of December 31, 2025 | |||||||
Consolidated Operating Entities | Consolidated Funds | Eliminations | Consolidated | ||||
(Dollars in millions) | |||||||
Assets | |||||||
Cash and cash equivalents | $ | $ | $ | $ | |||
Cash and cash equivalents held at Consolidated Funds | |||||||
Investments, including accrued performance allocations of $ | ( | ||||||
Investments of Consolidated Funds | |||||||
Due from affiliates and other receivables, net | ( | ||||||
Due from affiliates and other receivables of Consolidated Funds, net | |||||||
Fixed assets, net | |||||||
Lease right-of-use assets, net | |||||||
Deposits and other | |||||||
Intangible assets, net | |||||||
Deferred tax assets | |||||||
Total assets | $ | $ | $( | $ | |||
Liabilities and equity | |||||||
Debt obligations | $ | $ | $ | $ | |||
Loans payable of Consolidated Funds | ( | ||||||
Accounts payable, accrued expenses and other liabilities | |||||||
Accrued compensation and benefits | |||||||
Due to affiliates | |||||||
Deferred revenue | |||||||
Deferred tax liabilities | |||||||
Other liabilities of Consolidated Funds | ( | ||||||
Lease liabilities | |||||||
Accrued giveback obligations | |||||||
Total liabilities | ( | ||||||
Common stock | |||||||
Additional paid-in capital | ( | ||||||
Retained earnings | |||||||
Accumulated other comprehensive loss | ( | ( | |||||
Non-controlling interests in consolidated entities | |||||||
Total equity | ( | ||||||
Total liabilities and equity | $ | $ | $( | $ | |||
Three Months Ended March 31, 2026 | |||||||
Consolidated Operating Entities | Consolidated Funds | Eliminations | Consolidated | ||||
(Dollars in millions) | |||||||
Revenues | |||||||
Fund management fees | $ | $ | $( | $ | |||
Incentive fees | |||||||
Investment income (loss) | |||||||
Performance allocations | ( | ( | ( | ||||
Principal investment income (loss) | ( | ||||||
Total investment loss | ( | ( | |||||
Interest and other income | ( | ||||||
Interest and other income of Consolidated Funds | |||||||
Total revenues | |||||||
Expenses | |||||||
Compensation and benefits | |||||||
Cash-based compensation and benefits | |||||||
Equity-based compensation | |||||||
Performance allocations and incentive fee related compensation | ( | ( | |||||
Total compensation and benefits | ( | ( | |||||
General, administrative and other expenses | |||||||
Interest | |||||||
Interest and other expenses of Consolidated Funds | ( | ||||||
Total expenses | ( | ||||||
Other loss | |||||||
Net investment loss of Consolidated Funds | ( | ( | |||||
Loss before benefit for income taxes | ( | ( | ( | ||||
Benefit for income taxes | ( | ( | |||||
Net loss | ( | ( | ( | ||||
Net loss attributable to non-controlling interests in consolidated entities | ( | ( | ( | ||||
Net loss attributable to The Carlyle Group Inc. | $( | $( | $ | $( | |||
Three Months Ended March 31, 2025 | |||||||
Consolidated Operating Entities | Consolidated Funds | Eliminations | Consolidated | ||||
(Dollars in millions) | |||||||
Revenues | |||||||
Fund management fees | $ | $ | $( | $ | |||
Incentive fees | ( | ||||||
Investment income | |||||||
Performance allocations | ( | ||||||
Principal investment loss | ( | ( | ( | ||||
Total investment income | ( | ||||||
Interest and other income | ( | ||||||
Interest and other income of Consolidated Funds | |||||||
Total revenues | ( | ||||||
Expenses | |||||||
Compensation and benefits | |||||||
Cash-based compensation and benefits | |||||||
Equity-based compensation | |||||||
Performance allocations and incentive fee related compensation | |||||||
Total compensation and benefits | |||||||
General, administrative and other expenses | ( | ||||||
Interest | |||||||
Interest and other expenses of Consolidated Funds | ( | ||||||
Total expenses | ( | ||||||
Other income | |||||||
Net investment income of Consolidated Funds | |||||||
Income before provision for income taxes | ( | ||||||
Provision for income taxes | |||||||
Net income | ( | ||||||
Net income attributable to non-controlling interests in consolidated entities | |||||||
Net income attributable to The Carlyle Group Inc. | $ | $ | $( | $ | |||
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Cash flows from operating activities | |||
Net income (loss) | $( | $ | |
Adjustments to reconcile net income to net cash flows from operating activities: | |||
Depreciation and amortization | |||
Equity-based compensation | |||
Non-cash performance allocations and incentive fees | |||
Non-cash principal investment (income) loss | |||
Other non-cash amounts | ( | ||
Purchases of investments | ( | ( | |
Proceeds from the sale of investments | |||
Payments of contingent consideration | ( | ||
Change in deferred taxes, net | ( | ( | |
Change in due from affiliates and other receivables | ( | ||
Change in deposits and other | ( | ||
Change in accounts payable, accrued expenses and other liabilities | ( | ( | |
Change in accrued compensation and benefits | ( | ( | |
Change in due to affiliates | |||
Change in lease right-of-use assets and lease liabilities | ( | ( | |
Change in deferred revenue | |||
Net cash provided by operating activities | |||
Cash flows from investing activities | |||
Purchases of fixed assets, net | ( | ( | |
Net cash used in investing activities | ( | ( | |
Cash flows from financing activities | |||
Payments on CLO borrowings | ( | ( | |
Proceeds from CLO borrowings, net of financing costs | |||
Dividends to common stockholders | ( | ( | |
Contributions from non-controlling interest holders | |||
Distributions to non-controlling interest holders | ( | ( | |
Common shares repurchased and net share settlement of equity-based awards | ( | ( | |
Change in due to/from affiliates financing activities | |||
Net cash used in financing activities | ( | ( | |
Effect of foreign exchange rate changes | ( | ||
Decrease in cash, cash equivalents and restricted cash | ( | ( | |
Cash, cash equivalents and restricted cash, beginning of period | |||
Cash, cash equivalents and restricted cash, end of period | $ | $ | |
Reconciliation of cash, cash equivalents and restricted cash, end of period: | |||
Cash and cash equivalents | $ | $ | |
Restricted cash | |||
Total cash, cash equivalents and restricted cash, end of period | $ | $ | |
Cash and cash equivalents held at Consolidated Funds | $ | $ | |
Global Private Equity | $159.0 | Global Credit | $209.5 | |
Corporate Private Equity | $97.8 | Insurance Solutions 4 | $85.7 | |
U.S. Buyout (CP) | 47.7 | Liquid Credit | $47.7 | |
Asia Buyout (CAP) | 10.7 | U.S. CLOs | 33.5 | |
Europe Buyout (CEP) | 9.2 | Europe CLOs | 9.8 | |
Japan Buyout (CJP) | 6.5 | CLO Investment Products | 2.4 | |
Carlyle Global Partners (CGP) | 6.4 | Revolving Credit | 2.0 | |
Europe Technology (CETP) | 5.3 | Private Credit | $76.1 | |
U.S. Growth (CP Growth / CEOF) | 3.2 | Opportunistic Credit (CCOF / CSP) | 20.3 | |
Life Sciences (ABV / ACCD) | 2.3 | Direct Lending 5 | 14.0 | |
Asia Growth (CAP Growth / CAGP) | 1.1 | Aviation Finance (SASOF / CALF) | 12.5 | |
Other 1 | 5.5 | Asset-Backed Finance | 11.8 | |
Real Estate | $36.3 | Cross-Platform Credit (incl. CTAC) | 10.1 | |
U.S. Real Estate (CRP) | 25.3 | Infrastructure Credit (CICF) | 7.0 | |
Core Plus Real Estate (CPI) | 8.4 | Other 6 | 0.5 | |
International Real Estate (CER) | 2.6 | |||
Infrastructure & Natural Resources | $24.9 | Carlyle AlpInvest | $106.9 | |
NGP Energy 2 | 11.5 | Secondaries & Portfolio Finance (ASF / ASPF) | $47.6 | |
Infrastructure and Renewable Energy 3 | 7.1 | Co-Investments (ACF) | $23.9 | |
International Energy (CIEP) | 6.3 | Primary Investments & Other 7 | $35.4 | |

As of March 31, | |||
2026 | 2025 | ||
Consolidated Results | (Dollars in millions) | ||
Components of Fee-earning AUM | |||
Fee-earning AUM based on capital commitments | $71,716 | $60,730 | |
Fee-earning AUM based on invested capital | 78,378 | 82,747 | |
Fee-earning AUM based on collateral balances, at par | 42,344 | 44,359 | |
Fee-earning AUM based on net asset value | 32,079 | 24,411 | |
Fee-earning AUM based on fair value and other | 108,840 | 101,596 | |
Balance, End of Period(1) | $333,357 | $313,843 | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
Consolidated Results (Dollars in millions) | |||
Fee-earning AUM Rollforward | |||
Balance, Beginning of Period | $336,778 | $304,358 | |
Inflows(1) | 7,637 | 11,866 | |
Outflows (including realizations)(2) | (8,814) | (5,606) | |
Market Activity & Other(3) | (1,541) | 1,430 | |
Foreign Exchange(4) | (703) | 1,795 | |
Balance, End of Period | $333,357 | $313,843 | |

Three Months Ended March 31, 2026 | |
Consolidated Results (Dollars in millions) | |
Total AUM Rollforward | |
Balance, Beginning of Period | $476,867 |
Inflows(1) | 12,978 |
Outflows (including realizations)(2) | (13,526) |
Market Activity & Other(3) | 96 |
Foreign Exchange(4) | (997) |
Balance, End of Period | $475,418 |
Three Months Ended March 31, | Change | ||||||
2026 | 2025 | $ | % | ||||
(Dollars in millions) | |||||||
Revenues | |||||||
Fund management fees | $584.0 | $586.1 | $(2.1) | 0% | |||
Incentive fees | 51.7 | 43.2 | 8.5 | 20% | |||
Investment income (loss) | |||||||
Performance allocations | (681.1) | 222.9 | (904.0) | NM | |||
Principal investment income (loss) | 64.4 | (63.1) | 127.5 | NM | |||
Total investment income (loss) | (616.7) | 159.8 | (776.5) | NM | |||
Interest and other income | 55.3 | 50.6 | 4.7 | 9% | |||
Interest and other income of Consolidated Funds | 179.7 | 133.4 | 46.3 | 35% | |||
Total revenues | 254.0 | 973.1 | (719.1) | (74)% | |||
Expenses | |||||||
Compensation and benefits | |||||||
Cash-based compensation and benefits | 227.1 | 218.4 | 8.7 | 4% | |||
Equity-based compensation | 119.8 | 103.5 | 16.3 | 16% | |||
Performance allocations and incentive fee related compensation | (367.9) | 171.4 | (539.3) | NM | |||
Total compensation and benefits | (21.0) | 493.3 | (514.3) | NM | |||
General, administrative and other expenses | 184.6 | 173.6 | 11.0 | 6% | |||
Interest | 38.6 | 27.8 | 10.8 | 39% | |||
Interest and other expenses of Consolidated Funds | 166.4 | 113.5 | 52.9 | 47% | |||
Total expenses | 368.6 | 808.2 | (439.6) | (54)% | |||
Other income (loss) | |||||||
Net investment income (loss) of Consolidated Funds | (64.4) | 6.1 | (70.5) | NM | |||
Income (loss) before provision for income taxes | (179.0) | 171.0 | (350.0) | NM | |||
Provision (benefit) for income taxes | (37.1) | 12.4 | (49.5) | NM | |||
Net income (loss) | (141.9) | 158.6 | (300.5) | NM | |||
Net income (loss) attributable to non-controlling interests in consolidated entities | (9.7) | 28.6 | (38.3) | NM | |||
Net income (loss) attributable to The Carlyle Group Inc. Common Stockholders | $(132.2) | $130.0 | $(262.2) | NM | |||
Three Months Ended March 31, | |
2026 v. 2025 | |
(Dollars in millions) | |
Higher management fees from the commencement of the investment period for certain newly raised funds which charge fees based on commitments and the impact of incremental fundraising in funds which activated fees in a prior period | $58.7 |
Net lower management fees resulting from the change in basis from commitments to invested capital and step-downs in rate for certain funds, and the impact of net investment activity in funds whose management fees are based on invested capital | (17.0) |
Decrease in catch-up management fees from subsequent closes of funds that are in the fundraising period | (15.9) |
Lower transaction and portfolio advisory fees | (27.4) |
All other changes | (0.5) |
Total decrease in Fund management fees(1) | $(2.1) |
Three Months Ended March 31, | Change | ||||||
2026 | 2025 | $ | % | ||||
(Dollars in millions) | |||||||
Performance allocations | $(681.1) | $222.9 | $(904.0) | NM | |||
Principal investment income (loss): | |||||||
Investment income (loss) from NGP, which includes performance allocations | 55.3 | (107.2) | 162.5 | NM | |||
Investment income (loss) from our carry funds: | |||||||
Global Private Equity | (1.7) | 11.5 | (13.2) | NM | |||
Global Credit | 3.1 | 0.8 | 2.3 | 288% | |||
Carlyle AlpInvest | (3.0) | 2.2 | (5.2) | NM | |||
Investment loss from our CLOs | (9.7) | (0.8) | (8.9) | NM | |||
Investment income from Carlyle FRL | 6.8 | 13.9 | (7.1) | (51)% | |||
Investment income from our other Global Credit products | 1.0 | 6.4 | (5.4) | (84)% | |||
Investment income from our other Carlyle AlpInvest products | 13.4 | 11.6 | 1.8 | 16% | |||
Investment loss on foreign currency hedges | (1.0) | (0.8) | (0.2) | 25% | |||
All other investment loss | 0.2 | (0.7) | 0.9 | (129)% | |||
Total Principal investment income (loss) | 64.4 | (63.1) | 127.5 | NM | |||
Total Investment income (loss) | $(616.7) | $159.8 | $(776.5) | NM | |||
Three Months Ended March 31, | Change | ||||||
2026 | 2025 | $ | % | ||||
(Dollars in millions) | |||||||
Global Private Equity | $(698.1) | $85.0 | $(783.1) | NM | |||
Global Credit | 36.7 | 79.0 | (42.3) | (54)% | |||
Carlyle AlpInvest | (19.7) | 58.9 | (78.6) | NM | |||
Total performance allocations | $(681.1) | $222.9 | $(904.0) | NM | |||
Three Months Ended March 31, | Change | ||||||
2026 | 2025 | $ | % | ||||
(Dollars in millions) | |||||||
Net realized gains (losses) on investments of Consolidated Funds (excluding CLOs) | $20.3 | $13.9 | $6.4 | NM | |||
Net change in unrealized gains (losses) on investments of Consolidated Funds (excluding CLOs) | (49.8) | 2.3 | (52.1) | NM | |||
Net realized and unrealized gains (losses) on investments of Consolidated Funds (excluding CLOs) | (29.5) | 16.2 | (45.7) | NM | |||
Gains (losses) on investments of consolidated CLOs | (219.1) | (9.2) | (209.9) | NM | |||
Gains (losses) from liabilities of consolidated CLOs | 184.2 | (0.9) | 185.1 | NM | |||
Net gains (losses) from consolidated CLOs | (34.9) | (10.1) | (24.8) | NM | |||
Total net investment income (loss) of Consolidated Funds | $(64.4) | $6.1 | $(70.5) | NM | |||
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Total segment revenues | $750.9 | $1,043.2 | |
Total segment expenses | 423.9 | 587.8 | |
(=) Distributable Earnings | $327.0 | $455.4 | |
(-) Realized net performance revenues | 20.5 | 127.4 | |
(-) Realized principal investment income | 28.2 | 30.0 | |
(+) Net interest | 21.7 | 12.6 | |
(=) Fee Related Earnings | $300.0 | $310.6 | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Segment revenues | |||
Fund level fee revenues | |||
Fund management fees | $544.5 | $525.5 | |
Portfolio advisory and transaction fees, net and other | 54.1 | 77.9 | |
Fee related performance revenues | 45.4 | 39.5 | |
Total fund level fee revenues | 644.0 | 642.9 | |
Realized performance revenues | 61.8 | 355.1 | |
Realized principal investment income | 28.2 | 30.0 | |
Interest income | 16.9 | 15.2 | |
Total Segment Revenues | $750.9 | $1,043.2 | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Segment expenses | |||
Compensation and benefits | |||
Cash-based compensation and benefits | $218.5 | $224.0 | |
Realized performance revenue related compensation | 41.3 | 227.7 | |
Total compensation and benefits | 259.8 | 451.7 | |
General, administrative, and other indirect expenses | 109.6 | 95.6 | |
Depreciation and amortization expense | 15.9 | 12.7 | |
Interest expense | 38.6 | 27.8 | |
Total Segment Expenses | $423.9 | $587.8 | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Income (loss) before provision for income taxes | $(179.0) | $171.0 | |
Adjustments: | |||
Net unrealized performance and fee related performance revenues | 254.5 | 90.0 | |
Unrealized principal investment (income) loss | 68.3 | (17.0) | |
Equity-based compensation(1) | 121.8 | 104.7 | |
Acquisition or disposition-related charges, including amortization of intangibles and impairment | 46.4 | 122.2 | |
Tax (expense) benefit associated with certain foreign performance revenues | 0.7 | — | |
Net (income) loss attributable to non-controlling interests in consolidated entities | 9.7 | (28.6) | |
Other adjustments(2) | 4.6 | 13.1 | |
(=) Distributable Earnings | $327.0 | $455.4 | |
(-) Realized net performance revenues, net of related compensation(3) | 20.5 | 127.4 | |
(-) Realized principal investment income(3) | 28.2 | 30.0 | |
(+) Net interest | 21.7 | 12.6 | |
(=) Fee Related Earnings | $300.0 | $310.6 | |
Three Months Ended March 31, 2026 | |||||
Carlyle Consolidated | Adjustments(4) | Total Reportable Segments | |||
(Dollars in millions) | |||||
Performance revenues | $(681.1) | $742.9 | $61.8 | ||
Performance revenues related compensation expense | (367.9) | 409.2 | 41.3 | ||
Net performance revenues | $(313.2) | $333.7 | $20.5 | ||
Principal investment income (loss) | $64.4 | $(36.2) | $28.2 | ||
Three Months Ended March 31, 2025 | |||||
Carlyle Consolidated | Adjustments(4) | Total Reportable Segments | |||
(Dollars in millions) | |||||
Performance revenues | $222.9 | $132.2 | $355.1 | ||
Performance revenues related compensation expense | 171.4 | 56.3 | 227.7 | ||
Net performance revenues | $51.5 | $75.9 | $127.4 | ||
Principal investment income (loss) | $(63.1) | $93.1 | $30.0 | ||
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Global Private Equity | $149.9 | $265.6 | |
Global Credit | 98.2 | 110.5 | |
Carlyle AlpInvest | 78.9 | 79.3 | |
Distributable Earnings | $327.0 | $455.4 | |
Three Months Ended March 31, | Change | ||||||
2026 | 2025 | $ | % | ||||
(Dollars in millions) | |||||||
Segment revenues | |||||||
Fund level fee revenues | |||||||
Fund management fees | $284.3 | $283.0 | $1.3 | 0% | |||
Portfolio advisory and transaction fees, net and other | 6.8 | 14.5 | (7.7) | (53)% | |||
Fee related performance revenues | 2.1 | — | 2.1 | NM | |||
Total fund level fee revenues | 293.2 | 297.5 | (4.3) | (1)% | |||
Realized performance revenues | 29.7 | 317.1 | (287.4) | (91)% | |||
Realized principal investment income (loss) | 11.8 | 15.1 | (3.3) | (22)% | |||
Interest income | 7.0 | 6.0 | 1.0 | 17% | |||
Total revenues | 341.7 | 635.7 | (294.0) | (46)% | |||
Segment expenses | |||||||
Compensation and benefits | |||||||
Cash-based compensation and benefits | 91.3 | 100.7 | (9.4) | (9)% | |||
Realized performance revenues related compensation | 19.8 | 200.4 | (180.6) | (90)% | |||
Total compensation and benefits | 111.1 | 301.1 | (190.0) | (63)% | |||
General, administrative, and other indirect expenses | 53.9 | 48.7 | 5.2 | 11% | |||
Depreciation and amortization expense | 8.4 | 6.9 | 1.5 | 22% | |||
Interest expense | 18.4 | 13.4 | 5.0 | 37% | |||
Total expenses | 191.8 | 370.1 | (178.3) | (48)% | |||
(=) Distributable Earnings | $149.9 | $265.6 | $(115.7) | (44)% | |||
(-) Realized net performance revenues | 9.9 | 116.7 | (106.8) | (92)% | |||
(-) Realized principal investment income (loss) | 11.8 | 15.1 | (3.3) | (22)% | |||
(+) Net interest | 11.4 | 7.4 | 4.0 | 54% | |||
(=) Fee Related Earnings | $139.6 | $141.2 | $(1.6) | (1)% | |||
Three Months Ended March 31, | |
2026 v. 2025 | |
(Dollars in millions) | |
Distributable Earnings, March 31, 2025 | $265.6 |
Increases (decreases): | |
Decrease in Fee related earnings | (1.6) |
Decrease in Realized net performance revenues | (106.8) |
Decrease in Realized principal investment income | (3.3) |
Increase in Net interest | (4.0) |
Total decrease | (115.7) |
Distributable Earnings, March 31, 2026 | $149.9 |
Three Months Ended March 31, | |
2026 v. 2025 | |
(Dollars in millions) | |
Fee Related Earnings, March 31, 2025 | $141.2 |
Increases (decreases): | |
Decrease in Fee revenues | (4.3) |
Decrease in Cash-based compensation and benefits | 9.4 |
Increase in General, administrative and other indirect expenses | (5.2) |
All other changes | (1.5) |
Total decrease | (1.6) |
Fee Related Earnings, March 31, 2026 | $139.6 |
Three Months Ended March 31, | |
2026 v. 2025 | |
(Dollars in millions) | |
Higher Fund management fees | $1.3 |
Lower Portfolio advisory and transaction fees, net and other | (7.7) |
Higher Fee related performance revenues | 2.1 |
Total decrease in fee revenues | $(4.3) |
As of March 31, | |||
2026 | 2025 | ||
Global Private Equity | (Dollars in millions) | ||
Components of Fee-earning AUM(1) | |||
Fee-earning AUM based on capital commitments | $41,123 | $35,147 | |
Fee-earning AUM based on invested capital | 47,334 | 52,949 | |
Fee-earning AUM based on net asset value | 8,271 | 7,311 | |
Fee-earning AUM based on lower of cost or fair value | 2,331 | 3,304 | |
Total Fee-earning AUM | $99,059 | $98,711 | |
Annualized Management Fee Rate(2) | 1.13% | 1.13% | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Balance, Beginning of Period | $101,366 | $98,033 | |
Inflows(1) | 1,107 | 1,497 | |
Outflows (including realizations)(2) | (3,274) | (1,477) | |
Market Activity & Other(3) | 111 | (50) | |
Foreign Exchange(4) | (251) | 708 | |
Balance, End of Period | $99,059 | $98,711 | |
Three Months Ended March 31, 2026 | |
(Dollars in millions) | |
Balance, Beginning of Period | $163,543 |
Inflows(1) | 2,243 |
Outflows (including realizations)(2) | (6,615) |
Market Activity & Other(3) | 218 |
Foreign Exchange(4) | (362) |
Balance, End of Period | $159,027 |
(Amounts in millions) | TOTAL INVESTMENTS | REALIZED/PARTIALLY REALIZED INVESTMENTS(12) | ||||||||||||
As of March 31, 2026 | As of March 31, 2026 | |||||||||||||
Fund (Fee Initiation Date/Step-down Date)(1) | Committed Capital(2) | Cumulative Invested Capital(3) | Percent Invested | Realized Value(4) | Remaining Fair Value(5) | MOIC (6) | Gross IRR (7)(8) | Net IRR (8)(9) | Net Accrued Carry/ (Giveback) (10) | Total Fair Value(11) | MOIC (6) | Gross IRR (7)(8) | ||
Corporate Private Equity | ||||||||||||||
CP VIII (Oct 2021 / Oct 2027) | $14,797 | $10,950 | 74% | $3,179 | $13,179 | 1.5x | 20% | 11% | $227 | $4,825 | 2.3x | 56% | ||
CP VII (May 2018 / Oct 2021) | $18,510 | $17,787 | 96% | $12,895 | $16,911 | 1.7x | 11% | 8% | $409 | $18,558 | 2.1x | 17% | ||
CP VI (May 2013 / May 2018) | $13,000 | $13,140 | 101% | $26,770 | $1,622 | 2.2x | 17% | 13% | $74 | $27,570 | 2.5x | 22% | ||
CP V (Jun 2007 / May 2013) | $13,720 | $13,238 | 96% | $28,123 | $227 | 2.1x | 18% | 14% | $16 | $28,134 | 2.3x | 20% | ||
CEP V (Oct 2018 / Oct 2024) | €6,416 | €6,075 | 95% | €1,794 | €4,211 | 1.0x | Neg | Neg | $— | €878 | 0.8x | Neg | ||
CEP IV (Sep 2014 / Oct 2018) | €3,670 | €3,964 | 108% | €6,215 | €1,238 | 1.9x | 16% | 11% | $48 | €6,258 | 2.1x | 20% | ||
CEP III (Jul 2007 / Dec 2013) | €5,295 | €5,177 | 98% | €11,731 | €18 | 2.3x | 19% | 14% | $— | €11,749 | 2.3x | 19% | ||
CAP VI (Jun 2024 / Jun 2030) | $2,886 | $213 | 7% | $— | $213 | 1.0x | NM | NM | $— | n/a | n/a | n/a | ||
CAP V (Jun 2018 / Jun 2024) | $6,554 | $7,020 | 107% | $3,063 | $5,975 | 1.3x | 9% | 4% | $— | $2,142 | 1.3x | 23% | ||
CAP IV (Jul 2013 / Jun 2018) | $3,880 | $4,146 | 107% | $8,713 | $266 | 2.2x | 18% | 13% | $19 | $8,707 | 2.4x | 21% | ||
CJP V (Nov 2024 / Nov 2030) | ¥434,325 | ¥92,965 | 21% | ¥— | ¥92,677 | 1.0x | NM | NM | $— | n/a | n/a | n/a | ||
CJP IV (Oct 2020 / Nov 2024) | ¥258,000 | ¥236,110 | 92% | ¥149,060 | ¥392,466 | 2.3x | 40% | 28% | $121 | ¥239,837 | 3.8x | 62% | ||
CJP III (Sep 2013 / Aug 2020) | ¥119,505 | ¥91,192 | 76% | ¥275,264 | ¥8,832 | 3.1x | 25% | 18% | $4 | ¥274,341 | 3.3x | 26% | ||
CGFSP III (Dec 2017 / Dec 2023) | $1,005 | $982 | 98% | $698 | $1,561 | 2.3x | 20% | 15% | $72 | $1,214 | 3.8x | 31% | ||
CGFSP II (Jun 2013 / Dec 2017) | $1,000 | $943 | 94% | $1,961 | $669 | 2.8x | 26% | 19% | $39 | $1,956 | 2.4x | 28% | ||
CP Growth (Oct 2021 / Oct 2027) | $1,283 | $657 | 51% | $— | $961 | 1.5x | 19% | 8% | $6 | n/a | n/a | n/a | ||
CEOF II (Nov 2015 / Mar 2020) | $2,400 | $2,370 | 99% | $4,109 | $1,406 | 2.3x | 20% | 15% | $70 | $4,651 | 2.5x | 22% | ||
CETP V (Mar 2022 / Jun 2028) | €3,180 | €1,893 | 60% | €— | €2,285 | 1.2x | NM | NM | $— | €— | 0.0x | NM | ||
CETP IV (Jul 2019 / Jun 2022) | €1,350 | €1,204 | 89% | €1,726 | €958 | 2.2x | 27% | 19% | $38 | €1,837 | 3.7x | 56% | ||
CETP III (Jul 2014 / Jul 2019) | €657 | €614 | 94% | €2,033 | €109 | 3.5x | 40% | 28% | $7 | €2,040 | 4.0x | 44% | ||
CGP II (Dec 2020 / Jan 2025) | $1,840 | $984 | 53% | $219 | $2,060 | 2.3x | 24% | 19% | $52 | n/a | n/a | n/a | ||
CGP (Jan 2015 / Mar 2021) | $3,588 | $3,267 | 91% | $1,956 | $2,359 | 1.3x | 4% | 3% | $4 | $2,263 | 1.5x | 7% | ||
All Other Active Funds & Vehicles(13) | $20,956 | n/a | $17,141 | $16,425 | 1.6x | 12% | 10% | $29 | $21,016 | 2.2x | 19% | |||
Fully Realized Funds & Vehicles(14)(15) | $35,376 | n/a | $81,333 | $2 | 2.3x | 28% | 20% | $— | $81,335 | 2.3x | 28% | |||
TOTAL CORPORATE PRIVATE EQUITY(16) | $156,515 | n/a | $219,948 | $77,121 | 1.9x | 25% | 17% | $1,232 | $231,873 | 2.3x | 26% | |||
Real Estate | ||||||||||||||
CRP X (Apr 2025 / Jul 2030) | $9,000 | $813 | 9% | $18 | $828 | 1.0x | NM | NM | $— | n/a | n/a | n/a | ||
CRP IX (Oct 2021 / Dec 2024) | $7,987 | $6,367 | 80% | $855 | $6,837 | 1.2x | 11% | 3% | $— | $772 | 1.5x | 26% | ||
CRP VIII (Aug 2017 / Oct 2021) | $5,505 | $4,987 | 91% | $6,042 | $2,674 | 1.7x | 31% | 17% | $69 | $6,076 | 2.1x | 46% | ||
CRP VII (Jun 2014 / Dec 2017) | $4,162 | $3,746 | 90% | $5,186 | $967 | 1.6x | 16% | 10% | $(28) | $5,142 | 1.7x | 20% | ||
CRP VI (Mar 2011 / Jun 2014) | $2,340 | $2,145 | 92% | $3,827 | $91 | 1.8x | 27% | 17% | $4 | $3,780 | 1.9x | 28% | ||
CPI (May 2016 / n/a) | $8,444 | $9,023 | n/a | $3,731 | $8,178 | 1.3x | 10% | 8% | n/a* | $2,253 | 1.7x | 12% | ||
All Other Active Funds & Vehicles(17) | $3,018 | n/a | $581 | $2,859 | 1.1x | 8% | 5% | $5 | $452 | 1.2x | 19% | |||
Fully Realized Funds & Vehicles(15)(18) | $14,226 | n/a | $21,598 | $13 | 1.5x | 9% | 5% | $— | $21,611 | 1.5x | 10% | |||
TOTAL REAL ESTATE(16) | $44,324 | n/a | $41,838 | $22,446 | 1.5x | 11% | 7% | $50 | $40,104 | 1.6x | 13% | |||
Infrastructure & Natural Resources | ||||||||||||||
CIEP II (Apr 2019 / Apr 2025) | $2,286 | $1,301 | 57% | $1,017 | $1,569 | 2.0x | 30% | 16% | $59 | $907 | 3.8x | NM** | ||
CIEP I (Sep 2013 / Jun 2019) | $2,500 | $2,470 | 99% | $3,622 | $1,559 | 2.1x | 16% | 10% | $73 | $4,346 | 2.2x | 17% | ||
CGIOF (Dec 2018 / Sep 2023) | $2,201 | $2,116 | 96% | $658 | $3,054 | 1.8x | 17% | 11% | $88 | $829 | 1.9x | 16% | ||
CRSEF II (Nov 2022 / Aug 2027) | $1,187 | $469 | 40% | $— | $946 | 2.0x | 44% | 29% | $25 | n/a | n/a | n/a | ||
NGP XIII (Feb 2023 / Feb 2028) | $2,300 | $1,025 | 45% | $134 | $1,485 | 1.6x | 49% | 32% | $9 | $158 | 4.8x | NM | ||
NGP XII (Jul 2017 / Jul 2022) | $4,304 | $3,680 | 85% | $4,882 | $2,826 | 2.1x | 21% | 15% | $36 | $4,535 | 2.8x | 33% | ||
NGP XI (Oct 2014 / Jul 2017) | $5,325 | $5,034 | 95% | $8,308 | $1,597 | 2.0x | 13% | 10% | $57 | $7,458 | 2.1x | 17% | ||
NGP X (Jan 2012 / Dec 2014) | $3,586 | $3,351 | 93% | $3,563 | $249 | 1.1x | 3% | —% | $— | $3,358 | 1.2x | 5% | ||
All Other Active Funds & Vehicles(19) | $5,242 | n/a | $3,557 | $5,507 | 1.7x | 17% | 13% | $45 | $3,654 | 2.4x | 21% | |||
Fully Realized Funds & Vehicles(15)(20) | $3,534 | n/a | $5,581 | $— | 1.6x | 8% | 5% | $— | $5,581 | 1.6x | 8% | |||
TOTAL INFRASTRUCTURE & NATURAL RESOURCES(16) | $28,221 | n/a | $31,322 | $18,792 | 1.8x | 13% | 9% | $391 | $30,825 | 2.0x | 14% | |||
Three Months Ended March 31, | Change | ||||||
2026 | 2025 | $ | % | ||||
(Dollars in millions) | |||||||
Segment Revenues | |||||||
Fund level fee revenues | |||||||
Fund management fees | $147.3 | $139.6 | $7.7 | 6% | |||
Portfolio advisory and transaction fees, net and other | 47.2 | 63.4 | (16.2) | (26)% | |||
Fee related performance revenues | 32.1 | 28.8 | 3.3 | 11% | |||
Total fund level fee revenues | 226.6 | 231.8 | (5.2) | (2)% | |||
Realized performance revenues | 10.7 | 13.3 | (2.6) | (20)% | |||
Realized principal investment income (loss) | 9.3 | 5.5 | 3.8 | 69% | |||
Interest income | 7.2 | 7.0 | 0.2 | 3% | |||
Total revenues | 253.8 | 257.6 | (3.8) | (1)% | |||
Segment Expenses | |||||||
Compensation and benefits | |||||||
Cash-based compensation and benefits | 93.3 | 89.0 | 4.3 | 5% | |||
Realized performance revenues related compensation | 6.7 | 7.9 | (1.2) | (15)% | |||
Total compensation and benefits | 100.0 | 96.9 | 3.1 | 3% | |||
General, administrative, and other indirect expenses | 35.5 | 35.0 | 0.5 | 1% | |||
Depreciation and amortization expense | 4.9 | 3.9 | 1.0 | 26% | |||
Interest expense | 15.2 | 11.3 | 3.9 | 35% | |||
Total expenses | 155.6 | 147.1 | 8.5 | 6% | |||
(=) Distributable Earnings | $98.2 | $110.5 | $(12.3) | (11)% | |||
(-) Realized net performance revenues | 4.0 | 5.4 | (1.4) | (26)% | |||
(-) Realized principal investment income (loss) | 9.3 | 5.5 | 3.8 | 69% | |||
(+) Net interest | 8.0 | 4.3 | 3.7 | 86% | |||
(=) Fee Related Earnings | $92.9 | $103.9 | $(11.0) | (11)% | |||
Three Months Ended March 31, | |
2026 v. 2025 | |
(Dollars in millions) | |
Distributable Earnings, March 31, 2025 | $110.5 |
Increases (decreases): | |
Decrease in Fee related earnings | (11.0) |
Decrease in Realized net performance revenues | (1.4) |
Increase in Realized principal investment income | 3.8 |
Increase in Net interest | (3.7) |
Total decrease | (12.3) |
Distributable Earnings, March 31, 2026 | $98.2 |
Three Months Ended March 31, | |
2026 v. 2025 | |
(Dollars in millions) | |
Fee Related Earnings, March 31, 2025 | $103.9 |
Increases (decreases): | |
Decrease in Fee revenues | (5.2) |
Increase in Cash-based compensation and benefits | (4.3) |
Increase in General, administrative and other indirect expenses | (0.5) |
All other changes | (1.0) |
Total decrease | (11.0) |
Fee Related Earnings, March 31, 2026 | $92.9 |
Three Months Ended March 31, | |
2026 v. 2025 | |
(Dollars in millions) | |
Higher Fund management fees | $7.7 |
Lower Portfolio advisory and transaction fees, net and other | (16.2) |
Higher Fee related performance revenues | 3.3 |
Total decrease in Fee revenues | $(5.2) |
As of March 31, | |||
2026 | 2025 | ||
Global Credit | (Dollars in millions) | ||
Components of Fee-earning AUM(1) | |||
Fee-earning AUM based on capital commitments | $2,549 | $2,467 | |
Fee-earning AUM based on invested capital | 21,787 | 20,624 | |
Fee-earning AUM based on collateral balances, at par | 42,344 | 44,359 | |
Fee-earning AUM based on net asset value | 4,225 | 3,278 | |
Fee-earning AUM based on fair value and other(2) | 95,533 | 90,003 | |
Total Fee-earning AUM | $166,438 | $160,731 | |
Annualized Management Fee Rate(3) | 0.35% | 0.35% | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Balance, Beginning of Period | $169,460 | $154,186 | |
Inflows(1) | 3,284 | 7,811 | |
Outflows (including realizations)(2) | (4,520) | (3,113) | |
Market Activity & Other(3) | (1,619) | 1,465 | |
Foreign Exchange(4) | (167) | 382 | |
Balance, End of Period | $166,438 | $160,731 | |
Three Months Ended March 31, 2026 | |
(Dollars in millions) | |
Balance, Beginning of Period | $211,328 |
Inflows(1) | 3,906 |
Outflows (including realizations)(2) | (4,715) |
Market Activity & Other(3) | (839) |
Foreign Exchange(4) | (185) |
Balance, End of Period | $209,495 |
(Dollars in millions) | TOTAL INVESTMENTS | |||||||||
As of March 31, 2026 | ||||||||||
Fund (Fee Initiation Date/Step-down Date)(11) | Committed Capital(12) | Cumulative Invested Capital (1) | Percent Invested | Realized Value (2) | Remaining Fair Value (3) | MOIC (4) | Gross IRR (5) (8) | Net IRR (6) (8) | Net Accrued Carry/(Giveback) (7) | |
Global Credit Carry Funds | ||||||||||
CCOF III - Levered (Feb 2023 / Oct 2028) | $4,678 | $4,150 | 89% | $861 | $4,102 | 1.2x | 25% | 16% | $28 | |
CCOF II (Nov 2020 / Mar 2026) | $4,430 | $5,956 | 134% | $4,791 | $3,560 | 1.4x | 14% | 10% | $111 | |
CCOF I (Nov 2017 / Sep 2022) | $2,373 | $3,544 | 149% | $3,908 | $1,254 | 1.5x | 16% | 11% | $28 | |
CSP IV (Apr 2016 / Dec 2020) | $2,500 | $2,500 | 100% | $1,747 | $1,836 | 1.4x | 10% | 5% | $— | |
CICF II (Mar 2024 / Dec 2029) | $1,379 | $317 | 23% | $180 | $167 | 1.1x | NM | NM | $— | |
SASOF III (Nov 2014 / n/a) | $833 | $991 | 119% | $1,289 | $78 | 1.4x | 19% | 12% | $6 | |
All Other Active Funds & Vehicles(9) | $13,081 | n/a | $6,249 | $10,597 | 1.3x | 11% | 9% | $99 | ||
Fully Realized Funds & Vehicles(10)(13) | $9,698 | n/a | $12,154 | $30 | 1.3x | 9% | 4% | $— | ||
TOTAL GLOBAL CREDIT CARRY FUNDS | $40,237 | n/a | $31,180 | $21,623 | 1.3x | 11% | 7% | $272 | ||
Three Months Ended March 31, | Change | ||||||
2026 | 2025 | $ | % | ||||
(Dollars in millions) | |||||||
Segment Revenues | |||||||
Fund level fee revenues | |||||||
Fund management fees | $112.9 | $102.9 | $10.0 | 10% | |||
Portfolio advisory and transaction fees, net and other | 0.1 | — | 0.1 | NM | |||
Fee related performance revenues | 11.2 | 10.7 | 0.5 | 5% | |||
Total fund level fee revenues | 124.2 | 113.6 | 10.6 | 9% | |||
Realized performance revenues | 21.4 | 24.7 | (3.3) | (13)% | |||
Realized principal investment income | 7.1 | 9.4 | (2.3) | (24)% | |||
Interest income | 2.7 | 2.2 | 0.5 | 23% | |||
Total revenues | 155.4 | 149.9 | 5.5 | 4% | |||
Segment Expenses | |||||||
Compensation and benefits | |||||||
Cash-based compensation and benefits | 33.9 | 34.3 | (0.4) | (1)% | |||
Realized performance revenues related compensation | 14.8 | 19.4 | (4.6) | (24)% | |||
Total compensation and benefits | 48.7 | 53.7 | (5.0) | (9)% | |||
General, administrative, and other indirect expenses | 20.2 | 11.9 | 8.3 | 70% | |||
Depreciation and amortization expense | 2.6 | 1.9 | 0.7 | 37% | |||
Interest expense | 5.0 | 3.1 | 1.9 | 61% | |||
Total expenses | 76.5 | 70.6 | 5.9 | 8% | |||
(=) Distributable Earnings | $78.9 | $79.3 | $(0.4) | (1)% | |||
(-) Realized net performance revenues | 6.6 | 5.3 | 1.3 | 25% | |||
(-) Realized principal investment income | 7.1 | 9.4 | (2.3) | (24)% | |||
(+) Net interest | 2.3 | 0.9 | 1.4 | 156% | |||
(=) Fee Related Earnings | $67.5 | $65.5 | $2.0 | 3% | |||
Three Months Ended March 31, | |
2026 v. 2025 | |
(Dollars in millions) | |
Distributable Earnings, March 31, 2025 | $79.3 |
Increases (decreases): | |
Increase in Fee related earnings | 2.0 |
Increase in Realized net performance revenues | 1.3 |
Decrease in Realized principal investment income | (2.3) |
Increase in Net interest | (1.4) |
Total decrease | (0.4) |
Distributable Earnings, March 31, 2026 | $78.9 |
Three Months Ended March 31, | |
2026 v. 2025 | |
(Dollars in millions) | |
Fee Related Earnings, March 31, 2025 | $65.5 |
Increases (decreases): | |
Increase in Fee revenues | 10.6 |
Decrease in Cash-based compensation and benefits | 0.4 |
Increase in General, administrative and other indirect expenses | (8.3) |
All other changes | (0.7) |
Total increase | 2.0 |
Fee Related Earnings, March 31, 2026 | $67.5 |
As of March 31, | |||
2026 | 2025 | ||
Carlyle AlpInvest | (Dollars in millions) | ||
Components of Fee-earning AUM(1) | |||
Fee-earning AUM based on capital commitments | $28,044 | $23,116 | |
Fee-earning AUM based on invested capital(2) | 9,257 | 9,174 | |
Fee-earning AUM based on net asset value | 19,583 | 13,822 | |
Fee-earning AUM based on lower of cost or fair market value and other | 10,976 | 8,289 | |
Total Fee-earning AUM | $67,860 | $54,401 | |
Annualized Management Fee Rate(3) | 0.67% | 0.66% | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Balance, Beginning of Period | $65,952 | $52,139 | |
Inflows(1) | 3,246 | 2,558 | |
Outflows (including realizations)(2) | (1,020) | (1,016) | |
Market Activity & Other(3) | (33) | 15 | |
Foreign Exchange(4) | (285) | 705 | |
Balance, End of Period | $67,860 | $54,401 | |
Three Months Ended March 31, 2026 | |
(Dollars in millions) | |
Balance, Beginning of Period | $101,996 |
Inflows(1) | 6,829 |
Outflows (including realizations)(2) | (2,196) |
Market Activity & Other(3) | 717 |
Foreign Exchange(4) | (450) |
Balance, End of Period | $106,896 |
(Amounts in millions) | TOTAL INVESTMENTS | ||||||||||
As of March 31, 2026 | |||||||||||
Carlyle AlpInvest (1)(8) | Vintage Year | Fund Size | Cumulative Invested Capital (2)(3) | Realized Value (3) | Remaining Fair Value (3) | Total Fair Value (3)(4) | MOIC (5) | Gross IRR (6)(10) | Net IRR (7)(10) | Net Accrued Carry/ (Giveback) (12) | |
(Reported in Local Currency, in Millions) | |||||||||||
SECONDARIES & PORTFOLIO FINANCE | |||||||||||
ASF VIII | 2024 | $13,422 | $7,321 | $308 | $8,990 | $9,297 | 1.3x | NM | NM | $59 | |
ASF VII | 2020 | $6,769 | $5,018 | $2,587 | $5,356 | $7,943 | 1.6x | 16% | 12% | $116 | |
ASF VII - SMAs | 2020 | €2,043 | €1,756 | €709 | €1,891 | €2,600 | 1.5x | 14% | 12% | $37 | |
ASF VI | 2017 | $3,333 | $2,814 | $3,172 | $1,465 | $4,637 | 1.6x | 14% | 11% | $57 | |
ASF VI - SMAs | 2017 | €2,817 | €2,663 | €2,825 | €1,430 | €4,255 | 1.6x | 13% | 11% | $49 | |
ASF V | 2012 | $756 | $673 | $1,101 | $94 | $1,195 | 1.8x | 18% | 14% | $4 | |
ASF V - SMAs | 2012 | €3,916 | €3,975 | €7,015 | €329 | €7,344 | 1.8x | 21% | 19% | $7 | |
SMAs 2009-2011 | 2010 | €1,859 | €1,952 | €3,368 | €33 | €3,401 | 1.7x | 19% | 18% | $— | |
ASPF II | 2023 | $2,227 | $1,586 | $307 | $1,568 | $1,875 | 1.2x | 29% | 21% | $14 | |
All Other Active Funds & Vehicles (9) | Various | $2,002 | $538 | $2,210 | $2,748 | 1.4x | 18% | 14% | $36 | ||
Fully Realized Funds & Vehicles | Various | €4,388 | €7,149 | €12 | €7,161 | 1.6x | 19% | 18% | $— | ||
CO-INVESTMENTS | |||||||||||
ACF IX | 2023 | $4,120 | $2,431 | $148 | $2,697 | $2,845 | 1.2x | 15% | 10% | $7 | |
ACF IX - SMAs | 2023 | $1,016 | $382 | $22 | $433 | $455 | 1.2x | 16% | 13% | $3 | |
ACF VIII | 2021 | $3,614 | $3,450 | $538 | $4,340 | $4,878 | 1.4x | 10% | 8% | $38 | |
ACF VIII - SMAs | 2021 | $1,099 | $1,007 | $160 | $1,253 | $1,413 | 1.4x | 11% | 9% | $12 | |
ACF VII | 2017 | $1,688 | $1,682 | $1,903 | $1,361 | $3,264 | 1.9x | 14% | 11% | $56 | |
ACF VII - SMAs | 2017 | €1,452 | €1,398 | €1,298 | €1,270 | €2,567 | 1.8x | 13% | 11% | $40 | |
SMAs 2014-2016 | 2014 | €1,274 | €1,073 | €2,550 | €180 | €2,730 | 2.5x | 24% | 22% | $3 | |
SMAs 2012-2013 | 2012 | €1,124 | €1,022 | €2,800 | €128 | €2,927 | 2.9x | 28% | 26% | $1 | |
SMAs 2009-2010 | 2010 | €1,475 | €1,332 | €3,540 | €418 | €3,958 | 3.0x | 23% | 21% | $— | |
Strategic SMAs | Various | $5,075 | $2,870 | $5,474 | $8,343 | 1.6x | 15% | 14% | $80 | ||
All Other Active Funds & Vehicles (9) | Various | €66 | €164 | €5 | €169 | 2.6x | 36% | 34% | $— | ||
Fully Realized Funds & Vehicles | Various | €5,855 | €10,001 | €— | €10,001 | 1.7x | 15% | 13% | $— | ||
PRIMARY INVESTMENTS | |||||||||||
SMAs 2024-2026 | 2024 | $4,623 | $328 | $12 | $323 | $335 | 1.0x | NM | NM | $— | |
SMAs 2021-2023 | 2021 | €4,673 | €2,033 | €172 | €2,293 | €2,466 | 1.2x | 12% | 11% | $1 | |
SMAs 2018-2020 | 2018 | $3,116 | $2,714 | $965 | $3,127 | $4,092 | 1.5x | 14% | 13% | $4 | |
SMAs 2015-2017 | 2015 | €2,501 | €2,510 | €2,974 | €2,016 | €4,990 | 2.0x | 19% | 18% | $8 | |
SMAs 2012-2014 | 2012 | €5,080 | €5,783 | €9,943 | €2,712 | €12,655 | 2.2x | 17% | 17% | $10 | |
SMAs 2009-2011 | 2009 | €4,877 | €5,588 | €10,581 | €1,363 | €11,944 | 2.1x | 17% | 16% | $1 | |
SMAs 2006-2008 | 2005 | €11,500 | €12,991 | €21,798 | €993 | €22,791 | 1.8x | 10% | 10% | $— | |
SMAs 2003-2005 | 2003 | €4,628 | €4,933 | €7,856 | €117 | €7,973 | 1.6x | 10% | 9% | $— | |
All Other Active Funds & Vehicles (9) | Various | €1,771 | €1,804 | €210 | €2,014 | 1.1x | 3% | 2% | $— | ||
Fully Realized Funds & Vehicles | Various | €4,798 | €7,823 | €19 | €7,842 | 1.6x | 12% | 11% | $— | ||
TOTAL CARLYLE ALPINVEST (USD)(11) | $112,521 | $135,082 | $56,486 | $191,568 | 1.7x | 13% | 13% | $643 | |||
Accrued Performance Allocations(1) | Accrued Giveback Obligation | Net Accrued Performance Revenues | |||
(Dollars in millions) | |||||
Global Private Equity | $4,324.3 | $(76.5) | $4,247.8 | ||
Global Credit | 740.2 | (25.5) | 714.7 | ||
Carlyle AlpInvest | 1,800.9 | — | 1,800.9 | ||
Total | $6,865.4 | $(102.0) | $6,763.4 | ||
Plus: Accrued performance allocations from NGP Carry Funds(2) | 368.0 | ||||
Less: Accrued performance allocation-related compensation | (4,614.8) | ||||
Plus: Receivable for giveback obligations from current and former employees | 34.6 | ||||
Less: Deferred taxes on certain foreign accrued performance allocations | (14.9) | ||||
Less/Plus: Net accrued performance allocations/giveback obligations attributable to non-controlling interests in consolidated entities | 6.3 | ||||
Plus: Net accrued performance allocations attributable to Consolidated Funds, eliminated in consolidation | 20.8 | ||||
Net accrued performance revenues before timing differences | 2,563.4 | ||||
Less/Plus: Timing differences between the period when accrued performance allocations/giveback obligations are realized and the period they are collected/distributed | 24.4 | ||||
Net accrued performance revenues attributable to The Carlyle Group Inc. | $2,587.8 | ||||
Carry Fund Appreciation/(Depreciation)(1) | Net Accrued Performance Revenues | ||||||||
Quarter-to-Date | Last Twelve Months | ||||||||
Q1 2025 | Q1 2026 | Q1 2025 | Q1 2026 | ||||||
Overall Carry Fund Appreciation/(Depreciation) | 2% | 1% | 8% | 7% | |||||
Global Private Equity: | 2% | —% | 8% | 6% | $1,673.3 | ||||
Corporate Private Equity | 2% | (2)% | 9% | 3% | 1,231.8 | ||||
Real Estate | 1% | 1% | 5% | 3% | 50.4 | ||||
Infrastructure & Natural Resources | 3% | 9% | 9% | 25% | 391.1 | ||||
Global Credit Carry Funds | 4% | 4% | 14% | 15% | 271.6 | ||||
Carlyle AlpInvest Carry Funds | 1% | —% | 5% | 5% | 642.9 | ||||
Net Accrued Performance Revenues | $2,587.8 | ||||||||
Investments in Carlyle Funds | Investments in NGP(1) | Total | |||
(Dollars in millions) | |||||
Investments, excluding performance allocations | $2,947.5 | $652.4 | $3,599.9 | ||
Less: Amounts attributable to non-controlling interests in consolidated entities | (374.6) | — | (374.6) | ||
Plus: Investments in Consolidated Funds, eliminated in consolidation | 963.8 | — | 963.8 | ||
Less: Strategic equity method investments in NGP Management | — | (238.7) | (238.7) | ||
Less: Investment in NGP general partners - accrued performance allocations | — | (368.0) | (368.0) | ||
Total investments attributable to The Carlyle Group Inc. | $3,536.7 | $45.7 | $3,582.4 | ||
Investments in Carlyle Funds, excluding CLOs: | |
Global Private Equity(1) | $1,251.7 |
Global Credit(2) | 1,317.1 |
Carlyle AlpInvest | 424.0 |
Total investments in Carlyle Funds, excluding CLOs | 2,992.8 |
Investments in CLOs | 443.2 |
Other investments | 146.4 |
Total investments attributable to The Carlyle Group Inc. | 3,582.4 |
CLO borrowings collateralized by investments attributable to The Carlyle Group Inc.(3) | (335.2) |
Total investments attributable to The Carlyle Group Inc., net of CLO borrowings | $3,247.2 |
Common Stock Dividends - Dividend Year 2026 | |||||
Quarter | Dividend per Common Share | Dividend to Common Stockholders | Record Date | Payment Date | |
(Dollars in millions, except per share data) | |||||
Q1 2026 | $0.35 | $126.0 | May 18, 2026 | May 28, 2026 | |
Total | $0.35 | $126.0 | |||
Common Stock Dividends - Dividend Year 2025 | |||||
Quarter | Dividend per Common Share | Dividend to Common Stockholders | Record Date | Payment Date | |
(Dollars in millions, except per share data) | |||||
Q1 2025 | $0.35 | $126.3 | May 19, 2025 | May 27, 2025 | |
Q2 2025 | 0.35 | 126.5 | August 18, 2025 | August 28, 2025 | |
Q3 2025 | 0.35 | 125.9 | November 10, 2025 | November 19, 2025 | |
Q4 2025 | 0.35 | 126.4 | February 16, 2026 | February 20, 2026 | |
Total | $1.40 | $505.1 | |||
Three Months Ended March 31, | |||
2026 | 2025 | ||
(Dollars in millions) | |||
Statements of Cash Flows Data | |||
Net cash provided by the Company’s operating activities | $34.9 | $164.2 | |
Net cash used in the Consolidated Funds’ operating activities, after eliminations | (1,277.3) | (516.3) | |
Net cash used in operating activities | (1,242.4) | (352.1) | |
Net cash used in investing activities | (28.1) | (16.7) | |
Net cash used in the Company’s financing activities | (292.3) | (219.3) | |
Net cash provided by the Consolidated Funds’ financing activities, after eliminations | 1,280.6 | 515.9 | |
Net cash provided by financing activities | 988.3 | 296.6 | |
Effect of foreign exchange rate changes | (8.7) | 5.0 | |
Net change in cash, cash equivalents and restricted cash | $(290.9) | $(67.2) | |
Apr. 1, 2026 to Dec. 31, 2026 | 2027-2028 | 2029-2030 | Thereafter | Total | |||||
(Dollars in millions) | |||||||||
Debt obligations(1) | $61.0 | $85.9 | $473.6 | $2,413.2 | $3,033.7 | ||||
Interest payable(2) | 112.7 | 292.9 | 264.3 | 1,666.0 | 2,335.9 | ||||
Other consideration(3) | 18.3 | 6.7 | — | — | 25.0 | ||||
Operating lease obligations(4) | 59.4 | 184.4 | 183.1 | 378.3 | 805.2 | ||||
Capital commitments to Carlyle funds(5) | 3,934.6 | — | — | — | 3,934.6 | ||||
Tax receivable agreement payments(6) | — | 8.0 | 15.0 | 41.1 | 64.1 | ||||
Loans payable of Consolidated Funds(7) | 327.9 | 871.5 | 870.3 | 13,093.7 | 15,163.4 | ||||
Unfunded commitments of the CLOs(8) | 18.6 | — | — | — | 18.6 | ||||
Consolidated contractual obligations | 4,532.5 | 1,449.4 | 1,806.3 | 17,592.3 | 25,380.5 | ||||
Loans payable of Consolidated Funds(7) | (327.9) | (871.5) | (870.3) | (13,093.7) | (15,163.4) | ||||
Capital commitments to Carlyle funds(5) | (3,105.9) | — | — | — | (3,105.9) | ||||
Unfunded commitments of the CLOs(8) | (18.6) | — | — | — | (18.6) | ||||
Carlyle Operating Entities contractual obligations | $1,080.1 | $577.9 | $936.0 | $4,498.6 | $7,092.6 | ||||
Three Months Ended March 31, | |
2026 | |
Common stock outstanding, beginning of period | 357,374,023 |
Shares issued | 3,797,044 |
Shares repurchased/retired | (1,331,853) |
Common stock outstanding, end of period | 359,839,214 |
Period | (a) Total number of shares purchased | (b) Average price paid per share | (c) Total number of shares purchased as part of publicly announced plans or programs | (d) Maximum number (or approximate dollar value) of shares that may yet be purchased under the plans or programs (3) |
(Dollars in millions, except share and per share data) | ||||
January 1, 2026 to January 31, 2026 (1) | — | $— | — | $604.3 |
February 1, 2026 to February 28, 2026 (1) | — | $— | — | $2,000.0 |
March 1, 2026 to March 31, 2026 (1)(2) | 1,331,853 | $48.80 | 1,331,853 | $1,935.0 |
Total | 1,331,853 | 1,331,853 | ||
Exhibit No. | Description |
3.1 | Amended and Restated Certificate of Incorporation of The Carlyle Group Inc. (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on June 2, 2023). |
3.2 | Bylaws of The Carlyle Group Inc. (incorporated by reference to Exhibit 3.3 to the Registrant’s Current Report on Form 8-K filed with the SEC on January 2, 2020). |
10.1*+ | Form of Global Restricted Stock Unit Agreement for Time-Based Awards. |
10.2*+ | Form of Global Restricted Stock Unit Agreement for Bonus Deferral Awards. |
22* | Senior and Subordinated Notes, Issuers, and Guarantors. |
31.1* | Certification of the principal executive officer pursuant to Rule 13a – 14(a). |
31.2* | Certification of the principal financial officer pursuant to Rule 13a – 14(a). |
32.1** | Certification of the principal executive officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
32.2** | Certification of the principal financial officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
101.INS | Inline XBRL Instance Document - the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
101.SCH | Inline XBRL Taxonomy Extension Schema Document. |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document. |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
104 | The cover page from The Carlyle Group Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, formatted in Inline XBRL (included within the Exhibit 101 attachments). |
* | Filed herewith. |
** | Furnished herewith. |
+ | Management contract or compensatory plan or arrangement in which directors and/or executive officers are eligible to participate. |
The Carlyle Group Inc. | ||||
Date: May 8, 2026 | By: | /s/ Justin V. Plouffe | ||
Name: | Justin V. Plouffe | |||
Title: | Chief Financial Officer | |||
(Principal Financial Officer and Authorized Officer) | ||||